|
Index of reports
> Life Threatening Events (18)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Invega (Paliperidone) life threatening events. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Invega side effects in male
Reported by a consumer/non-health professional from United States on 2012-08-06
Patient: male
Reactions: Movement Disorder, Weight Decreased, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Injury, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Dystonia, Grimacing, Condition Aggravated, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Suicide Attempt, Disturbance in Attention, Tardive Dyskinesia, Extrapyramidal Disorder, Gait Disturbance, Hypertension
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cogentin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-12-11
Invega
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2008-05-01
End date: 2009-11-01
Risperdal
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2010-07-07
End date: 2011-02-02
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Dosage: ndc 050468-306
Indication: Schizophrenia, Paranoid Type
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Indication: Major Depression
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Indication: Bipolar Disorder
Start date: 2009-01-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Zyprexa
Indication: Schizophrenia
Possible Invega side effects in male
Reported by a consumer/non-health professional from United States on 2012-07-03
Patient: male
Reactions: Weight Decreased, Movement Disorder, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Injury, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Grimacing, Dystonia, Condition Aggravated, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Disturbance in Attention, Suicide Attempt, Tardive Dyskinesia, Gait Disturbance, Extrapyramidal Disorder, Hypertension
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cogentin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-12-11
Invega
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2008-05-01
End date: 2009-11-01
Risperdal
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2010-07-07
End date: 2011-02-02
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Indication: Bipolar Disorder
Start date: 2009-01-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Indication: Major Depression
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Dosage: ndc 050468-306
Indication: Schizophrenia, Paranoid Type
Start date: 2010-04-07
End date: 2011-02-02
Zyprexa
Indication: Schizophrenia
Possible Invega side effects in male
Reported by a physician from United States on 2012-06-26
Patient: male
Reactions: Weight Decreased, Movement Disorder, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Injury, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Grimacing, Dystonia, Abnormal Behaviour, Condition Aggravated, Torticollis, Muscle Twitching, Dissociation, Suicide Attempt, Disturbance in Attention, Gait Disturbance, Extrapyramidal Disorder, Tardive Dyskinesia, Hypertension
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cogentin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-12-11
Invega
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2008-05-01
End date: 2009-11-01
Risperdal
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2010-07-07
End date: 2011-02-02
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Indication: Major Depression
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Dosage: ndc 050468-306
Indication: Schizophrenia, Paranoid Type
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Indication: Bipolar Disorder
Start date: 2009-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Zyprexa
Indication: Schizophrenia
Possible Invega side effects in male
Reported by a physician from Denmark on 2012-06-25
Patient: male, weighing 85.0 kg (187.0 pounds)
Reactions: Hypersensitivity, Suffocation Feeling, Headache, Hypoaesthesia, Paraesthesia
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Invega
Other drugs received by patient: Lyrica; Amisulprid; Seroquel; Propranolol
Possible Invega side effects in female
Reported by a physician from China on 2012-05-03
Patient: female, weighing 50.0 kg (110.0 pounds)
Reactions: Multiple Drug Overdose
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Clonazepam
Dosage: uncounted tablets
Administration route: Oral
Indication: Schizophrenia
Start date: 2011-08-13
End date: 2011-08-13
Invega
Administration route: Oral
Indication: Schizophrenia
Invega
Administration route: Oral
Start date: 2011-08-13
End date: 2011-08-13
Possible Invega side effects in female
Reported by a physician from China on 2012-05-01
Patient: female, weighing 50.0 kg (110.0 pounds)
Reactions: Multiple Drug Overdose
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Clonazepam
Dosage: uncounted tablets
Administration route: Oral
Indication: Schizophrenia
Start date: 2011-08-13
End date: 2011-08-13
Invega
Administration route: Oral
Indication: Schizophrenia
Invega
Administration route: Oral
Start date: 2011-08-13
End date: 2011-08-13
Possible Invega side effects in 27 year old female
Reported by a physician from Spain on 2012-04-23
Patient: 27 year old female
Reactions: Aspiration, Intentional Overdose, Drug Interaction, Depressed Level of Consciousness
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Invega
Other drugs received by patient possibly interacting with the suspect drug:
Akineton
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Clonazepam
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Escitalopram
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Seroquel
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Zyprexa
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Possible Invega side effects in male
Reported by a physician from China on 2012-03-26
Patient: male, weighing 57.0 kg (125.4 pounds)
Reactions: Cardiac Arrest
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Invega
Administration route: Oral
Indication: Schizophrenia
Propranolol Hydrochloride
Administration route: Oral
Indication: Tachycardia
Start date: 2011-10-17
Other drugs received by patient: Benzhexol Hydrochloride; Alprazolam
Possible Invega side effects in 21 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-20
Patient: 21 year old male
Reactions: Neuroleptic Malignant Syndrome
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Invega
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Invega Sustenna
Indication: Product Used FOR Unknown Indication
End date: 2011-11-01
Strattera
Indication: Product Used FOR Unknown Indication
Possible Invega side effects in male
Reported by a physician from China on 2012-02-15
Patient: male, weighing 57.0 kg (125.4 pounds)
Reactions: Cardiac Arrest
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Invega
Administration route: Oral
Indication: Schizophrenia
Propranolol Hydrochloride
Administration route: Oral
Indication: Tachycardia
Start date: 2011-10-17
Other drugs received by patient: Benzhexol Hydrochloride; Alprazolam
Possible Invega side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-09
Patient: male, weighing 81.7 kg (179.6 pounds)
Reactions: Agitation, Psychomotor Hyperactivity, Hallucination, Auditory, Major Depression, Anger, Suicidal Ideation, Hunger
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Abilify
Indication: Product Used FOR Unknown Indication
Invega
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-07-29
Invega Sustenna
Start date: 2011-08-05
End date: 2011-08-12
Invega Sustenna
Indication: Schizoaffective Disorder
Start date: 2011-07-29
Invega Sustenna
Start date: 2011-08-05
End date: 2011-08-12
Invega Sustenna
Indication: Psychotic Disorder
Start date: 2011-07-29
Other drugs received by patient: Risperdal; Cymbalta; Ambien; Cymbalta; Risperdal
Possible Invega side effects in female
Reported by a consumer/non-health professional from United States on 2012-01-27
Patient: female, weighing 59.0 kg (129.7 pounds)
Reactions: Adverse Event, Deep Vein Thrombosis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Invega
Other drugs received by patient: Seasonique
Possible Invega side effects in 42 year old male
Reported by a physician from Australia on 2012-01-20
Patient: 42 year old male
Reactions: Akathisia, Homicidal Ideation, Suicidal Ideation
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Invega
Possible Invega side effects in female
Reported by a physician from United States on 2012-01-19
Patient: female, weighing 59.0 kg (129.7 pounds)
Reactions: Deep Vein Thrombosis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Invega
Other drugs received by patient: Seasonique
Possible Invega side effects in 42 year old male
Reported by a physician from Australia on 2012-01-18
Patient: 42 year old male
Reactions: Akathisia, Homicidal Ideation, Suicidal Ideation
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Invega
Possible Invega side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2011-12-12
Patient: male, weighing 81.7 kg (179.6 pounds)
Reactions: Agitation, Psychomotor Hyperactivity, Hallucination, Auditory, Major Depression, Anger, Suicidal Ideation, Hunger
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Abilify
Indication: Product Used FOR Unknown Indication
Invega
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-07-29
Invega Sustenna
Indication: Schizoaffective Disorder
Start date: 2011-07-29
Invega Sustenna
Start date: 2011-08-05
End date: 2011-08-12
Invega Sustenna
Indication: Psychotic Disorder
Start date: 2011-07-29
Invega Sustenna
Start date: 2011-08-05
End date: 2011-08-12
Other drugs received by patient: Risperdal; Ambien; Cymbalta; Cymbalta; Risperdal
Possible Invega side effects in male
Reported by a health professional (non-physician/pharmacist) from Australia on 2011-12-09
Patient: male, weighing 80.0 kg (176.0 pounds)
Reactions: Electroencephalogram Abnormal, Blood Creatine Phosphokinase Increased, Liver Function Test Abnormal, Neuroleptic Malignant Syndrome, Convulsion
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Duloxetine Hydrochloride
Indication: Product Used FOR Unknown Indication
Invega
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2009-11-15
Lithium Carbonate
Indication: Product Used FOR Unknown Indication
Zolpidem Tartrate
Indication: Product Used FOR Unknown Indication
Possible Invega side effects in male
Reported by a health professional (non-physician/pharmacist) from Australia on 2011-12-01
Patient: male, weighing 80.0 kg (176.0 pounds)
Reactions: Electroencephalogram Abnormal, Blood Creatine Phosphokinase Increased, Liver Function Test Abnormal, Neuroleptic Malignant Syndrome, Convulsion
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Duloxetine Hydrochloride
Indication: Product Used FOR Unknown Indication
Invega
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2009-11-15
Lithium Carbonate
Indication: Product Used FOR Unknown Indication
Zolpidem Tartrate
Indication: Product Used FOR Unknown Indication
|
